1. Home
  2. ICUCW vs FFBC Comparison

ICUCW vs FFBC Comparison

Compare ICUCW & FFBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ICUCW
  • FFBC
  • Stock Information
  • Founded
  • ICUCW N/A
  • FFBC 1863
  • Country
  • ICUCW United States
  • FFBC United States
  • Employees
  • ICUCW 19
  • FFBC N/A
  • Industry
  • ICUCW Biotechnology: Pharmaceutical Preparations
  • FFBC Major Banks
  • Sector
  • ICUCW Health Care
  • FFBC Finance
  • Exchange
  • ICUCW Nasdaq
  • FFBC Nasdaq
  • Market Cap
  • ICUCW N/A
  • FFBC N/A
  • IPO Year
  • ICUCW 2021
  • FFBC N/A
  • Fundamental
  • Price
  • ICUCW $0.03
  • FFBC $24.09
  • Analyst Decision
  • ICUCW
  • FFBC Hold
  • Analyst Count
  • ICUCW 0
  • FFBC 4
  • Target Price
  • ICUCW N/A
  • FFBC $30.00
  • AVG Volume (30 Days)
  • ICUCW N/A
  • FFBC 506.3K
  • Earning Date
  • ICUCW N/A
  • FFBC 04-24-2025
  • Dividend Yield
  • ICUCW N/A
  • FFBC 4.04%
  • EPS Growth
  • ICUCW N/A
  • FFBC N/A
  • EPS
  • ICUCW N/A
  • FFBC 2.41
  • Revenue
  • ICUCW N/A
  • FFBC $763,657,000.00
  • Revenue This Year
  • ICUCW N/A
  • FFBC $18.87
  • Revenue Next Year
  • ICUCW N/A
  • FFBC $4.19
  • P/E Ratio
  • ICUCW N/A
  • FFBC $9.86
  • Revenue Growth
  • ICUCW N/A
  • FFBC N/A
  • 52 Week Low
  • ICUCW N/A
  • FFBC $20.59
  • 52 Week High
  • ICUCW N/A
  • FFBC $31.18
  • Technical
  • Relative Strength Index (RSI)
  • ICUCW N/A
  • FFBC 55.97
  • Support Level
  • ICUCW N/A
  • FFBC $23.46
  • Resistance Level
  • ICUCW N/A
  • FFBC $24.51
  • Average True Range (ATR)
  • ICUCW 0.00
  • FFBC 0.63
  • MACD
  • ICUCW 0.00
  • FFBC 0.20
  • Stochastic Oscillator
  • ICUCW 0.00
  • FFBC 85.46

About ICUCW SeaStar Medical Holding Corporation Warrant

SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. The Company is comprised of a single reportable segment, which is its Device Segment.

Share on Social Networks: